| 1 |
Labaki WW, Rosenberg SR. Chronic obstructive pulmonary disease[J]. Ann Intern Med, 2020, 173(3): 17-32.
|
| 2 |
王金诚，弋 可，曾 强，等. 绵阳市年龄≥40岁常住居民慢性阻塞性肺疾病流行病学调查及其影响因素分析[J]. 山东医药，2021, 61(5): 47-50.
|
| 3 |
吴 明，刘钦华，郭永明，等. 福州市40岁及以上人群慢性阻塞性肺疾病流行病学调查分析[J]. 国际呼吸杂志，2020, 40(2): 107-113.
|
| 4 |
Celli BR, Wedzicha JA. Update on clinical aspects of chronic obstructive pulmonary disease [J]. N Engl J Med, 2019, 381(13): 1257-1266.
|
| 5 |
樊楚明，杨欣悦，孔 晖，等. 慢性阻塞性肺疾病呼吸衰竭合并肺部真菌感染患者死亡的影响因素研究[J]. 中国全科医学，2015(7): 779-782.
|
| 6 |
Sorathia L. Palliative care in chronic obstructive pulmonary disease [J]. Med Clin North Am, 2019, 103(3): 517-526.
|
| 7 |
Ritchie AI, Wedzicha JA. Definition, causes, pathogenesis, and consequences of chronic obstructive pulmonary disease exacerbations[J]. Clin Chest Med, 2020, 41(3): 421-438.
|
| 8 |
中华医学会呼吸病学分会慢性阻塞性肺疾病学组. 慢性阻塞性肺疾病诊治指南(2013年修订版)[J]. 中华结核和呼吸杂志，2013, 36(4): 255-264.
|
| 9 |
Sardu C, Gargiulo G, Esposito G, et al. Impact of diabetes mellitus on clinical outcomes in patients affected by Covid-19 [J]. Cardiovasc Diabetol, 2020, 19(1): 76.
|
| 10 |
蒋林哲，王月华，王立波， 等. 实时荧光定量PCR检测结肠癌中HER2和TOPOⅡαmRNA的表达[J]. 现代医学，2020, 48(1): 26-30.
|
| 11 |
齐俊英，田德英. 感染性疾病诊疗指南[M]. 北京：科学出版社，2013: 124-135.
|
| 12 |
陈 杰，吴科芳. 慢性阻塞性肺疾病并发肺部曲霉菌感染的危险因素分析[J]. 国际流行病学传染病学杂志，2021, 48(4): 311-315.
|
| 13 |
任成山，王关嵩，钱桂生. 慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 127-141.
|
| 14 |
Rao W, Wang S, Duleba M, et al. Regenerative Metaplastic clones in COPD lung drive inflammation and fibrosis[J]. Cell, 2020, 181(4): 848-864.
|
| 15 |
Halpin D, Criner GJ, Papi A, et al. Global initiative for the diagnosis, management, and prevention of chronic obstructive lung disease. The 2020 GOLD science committee report on COVID-19 and chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2021, 203(1): 24-36.
|
| 16 |
Han H, Ma Q, Li C, et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors[J]. Emerg Microbes Infect, 2020, 9(1): 1123-1130.
|
| 17 |
王昌敏，陈 程，庞秀慧. 肺癌术后肺部感染患者血清CRP、TNF-α、IL-2水平变化及临床意义[J]. 癌症进展，2019, 17(19): 2296-2298, 2301.
|
| 18 |
张方园，张维文，魏 琰，等. 应激性高血糖与青年脑梗死患者肺部感染和TLR4/NF-κB信号通路及细胞免疫功能的关系[J]. 中华医院感染学杂志，2021, 31(20): 3139-3143.
|
| 19 |
刘 洋，于 洋，周 南，等. 鞣花酸抑制TLR4/NF-κB/Myd88信号通路减轻炎症反应改善肾缺血再灌注大鼠肾损伤[J]. 解剖科学进展，2020, 26(6): 100-104.
|
| 20 |
Li W, Dong M, Chu L, et al. MicroRNA451 relieves inflammation in cerebral ischemiareperfusion via the Tolllike receptor 4/MyD88/NFkappaB signaling pathway [J]. Mol Med Rep, 2019, 20(4): 3043-3054.
|
| 21 |
王天涯，袁 奇. 慢性阻塞性肺疾病合并肺部感染患者炎症指标变化及影响因素分析[J]．中国基层医药，2020, 27(21): 2582-2586.
|
| 22 |
Xu X, Piao HN, Aosai F, et al. Arctigenin protects against depression by inhibiting microglial activation and neuroinflammation via HMGB1/TLR4/NF-kappaB and TNF-alpha/TNFR1/NF-κappaB pathways[J]. Br J Pharmacol, 2020, 177(22): 5224-5245.
|
| 23 |
Yu R, Jiang S, Tao Y, et al. Inhibition of HMGB1 improves necrotizing enterocolitis by inhibiting NLRP3 via TLR4 and NF-kappaB signaling pathways[J]. J Cell Physiol, 2019, 234(8): 13431-13438.
|
| 24 |
李朝晖，李复红，韩 蓓，等. 慢性阻塞性肺部疾病并发肺部感染患者CRP、PCT、TLR4的表达及其临床意义[J]. 海南医学，2020, 31(13): 1655-1658.
|
| 25 |
Chumburidze-Areshidze N, Kezeli T, Avaliani Z, et al. The relationship between type-2 diabetes and tuberculosis[J]. Georgian Med News, 2020, 28(3): 69-74.
|
| 26 |
Hove-Skovsgaard M, Abildgaard J, Gelpi M, et al. No evidence of a synergistic effect of HIV infection and diabetes mellitus type 2 on fat distribution, plasma adiponectin or inflammatory markers[J]. BMC Infect Dis, 2020, 20(1): 882.
|